NSP1 |
Innate immune response blockage by promotion of mRNA degradation |
[[24], [25], [26], [27]] |
NSP2 |
Unknown function, binds to prohibiting proteins |
[28,29] |
NSP3 |
Papain lyase, cytokine expression promotion, blocking host innate immune response, activity of ADRP |
[[30], [31], [32], [33], [34], [35]] |
NSP4 |
Potential transmembrane scaffold protein, maintains DMVs proper structure |
[36,37] |
NSP5 |
Main protease (Mpro), viral polyprotein cleavage |
[38] |
NSP6 |
Potential transmembrane scaffold protein |
[39] |
NSP7 |
NSP7 forms a hexadecameric complex with NSP8. For RNA polymerase, it acts as a processivity clamp |
[40] |
NSP8 |
For RNA polymerase, it acts as a processivity clamp and also plays a role as a primase |
[41,42] |
NSP9 |
Binding protein for RNA |
[43] |
NSP10 |
It acts as a cofactor for NSP14 and 16 by forming a heterodimer with both of them and stimulating the activity of N viral exoribonuclease (ExoN) and O-methyl transferase |
[44,45] |
NSP12 |
RdRp) |
[46] |
NSP13 |
RNA Helicase, 5′ Triphosphatase |
[47,48] |
NSP14 |
Shows ExoNactivity which is important for viral genome proofreading, addition of 5′ cap to viral RNAs by MTase. |
[[49], [50], [51], [52]] |
NSP15 |
Endoribonuclease of virus |
[53,54] |
NSP16 |
O-methyl transferase (2′-O-MT); viral RNA shielding from MDA5 recognition |
[55,56] |